DEFERASIROX AND DEFEROXAMINE COMBINATION THERAPY: A CASE OF MANAGEMENT OF IRON OVERLOAD IN MYELODYSPLASTIC SYNDROME IN AN HEPATOPATHIC PATIENT.

被引：0
|
作者：
Cerchione, C. [1 ]
Cerciello, G. [1 ]
Della Pepa, R. [1 ]
Matarazzo, M. [1 ]
Alfinito, F. [1 ]
Pane, F. [1 ]
机构：
[1] Univ Federico II, Naples, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1847
引用
收藏
页码：713 / 713
页数：1
相关论文
共 50 条
  • [1] COMBINATION OF DEFERASIROX AND DEFEROXAMINE IN MANAGEMENT OF IRON OVERLOAD IN MYELODYSPLASTIC SYNDROMES (MDS): AN UPDATE IN A HEPATOPATIC PATIENT
    Cerchione, C.
    Cerciello, G.
    Della Pepa, R.
    Pugliese, N.
    Marano, L.
    Vitagliano, O.
    Matarazzo, M.
    Pane, F.
    Alfinito, F.
    HAEMATOLOGICA, 2013, 98 : 731 - 731
  • [2] Combination of deferasirox and deferoxamine in management of iron overload in myelodysplastic syndromes (MDS): An update in a hepatopatic patient
    Cerchione, C.
    Cerciello, G.
    Della Pepa, R.
    Pugliese, N.
    Marano, L.
    Vitagliano, O.
    Matarazzo, M.
    Pane, F.
    Alfinito, F.
    LEUKEMIA RESEARCH, 2013, 37 : S108 - S108
  • [3] Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease
    Cerchione, Claudio
    Cerciello, Giuseppe
    Avilia, Simona
    Della Pepa, Roberta
    Pugliese, Novella
    Picardi, Marco
    Catalano, Lucio
    Pane, Fabrizio
    BLOOD TRANSFUSION, 2018, 16 (01) : 32 - 35
  • [4] Combination therapy of deferasirox and deferoxamine shows significant improvements in markers of iron overload in a patient with β- thalassemia major and severe iron burden
    Voskaridou, Ersi
    Komninaka, Veroniki
    Karavas, Antonis
    Terpos, Evangelos
    Akianidis, Vasilis
    Christoulas, Dimitrios
    TRANSFUSION, 2014, 54 (03) : 646 - 649
  • [5] Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
    Wu, Dijiong
    Wen, Xiaowen
    Liu, Wenbin
    Hu, Huijin
    Ye, Baodong
    Zhou, Yuhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1081 - 1091
  • [6] Deferasirox for managing iron overload in people with myelodysplastic syndrome
    Meerpohl, Joerg J.
    Schell, Lisa K.
    Ruecker, Gerta
    Fleeman, Nigel
    Motschall, Edith
    Niemeyer, Charlotte M.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [7] Deferasirox for managing iron overload in people with myelodysplastic syndrome
    Meerpohl, Joerg J.
    Antes, Gerd
    Ruecker, Gerta
    Fleeman, Nigel
    Motschall, Edith
    Niemeyer, Charlotte M.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (11):
  • [8] Combination Therapy of Deferasirox and Deferoxamine As Paregoric Treatment of Severe Iron Overload in Patients with Thalassemia Major
    Ladis, Vassilis
    Kyriacopoulou, Dimitra
    Stokidis, Konstantinos
    Moira, Aggeliki
    Kattamis, Antonios
    BLOOD, 2012, 120 (21)
  • [9] A PATIENT WITH MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) AND IRON OVERLOAD TREATED WITH LENALIDOMIDE AND DEFERASIROX: A CASE REPORT
    Guaragna, G.
    Rinaldi, E.
    Girasoli, M.
    Spina, A.
    Mele, G.
    Quarta, G.
    Melpignano, A.
    HAEMATOLOGICA, 2017, 102 : 155 - 155
  • [10] Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Taher, Ali
    Kantarjian, Hagop M.
    ONCOLOGIST, 2009, 14 (05): : 489 - 496
12345